WebSep 28, 2024 · LONDON and NEW YORK, Sept. 28, 2024 (GLOBE NEWSWIRE) -- Tiziana Life Sciences plc (Nasdaq: TLSA / LSE: TILS) ("Tiziana" or the "Company"), a biotechnology company focused on innovative therapeutics for oncology, inflammation and infectious diseases, today announces that it has been notified that Panetta Partners Limited, an … WebJun 9, 2024 · Tiziana Life Sciences Ltd. Hana Malik, Business Development, and Investor Relations Manager +44 (0) 207 495 2379 email: [email protected]. Investors: Irina Koffler LifeSci Advisors, LLC 646.970.4681 [email protected]
Brittnie Panetta - Associate Attorney - Matthews & Associates
WebMay 20, 2024 · OKYO Pharma Limited: Gary S. Jacob, Chief Executive Officer Gabriele Cerrone, Non-Executive Chairman +44 (0)20 7495 2379: Optiva Securities Limited … WebJun 9, 2024 · Tiziana Life Sciences Ltd, a biotechnology company enabling breakthrough immunotherapies via novel routes of drug delivery, said it has been notified that Panetta Partners Limited, an entity in which Gabriele Cerrone, the company's executive chairman, has a beneficial interest, purchased 18,000 common shares at $0.80 per share. cherry poptart bigfoot
Tiziana Life Sciences plc: PDMR Dealing - Yahoo Finance
WebPANETTA PARTNERS, LTD. (Entity # 19991228723) is a Limited Partnership in New York, New York registered with the Colorado Department of State (CDOS). The entity was … WebMar 30, 2024 · OKYO Pharma Limited : Gary S. Jacob, Chief Executive Officer +44 (0)20 7495 2379 . Investor Relations : Paul Spencer +44 (0)20 7495 2379 : Broker : Robert Emmet, Optiva Securities Limited +44 (0)20 3981 4173 . Notes for Editors: About OKYO . OKYO Pharma Limited (LSE: OKYO; NASDAQ: OKYO) is a life sciences company … WebDec 7, 1999 · PANETTA PARTNERS, LTD. Company Number 19991228723 Status Voluntarily Dissolved Incorporation Date 7 December 1999 (about 23 years ago) … flights minneapolis to frankfurt